|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| Assets | ||||
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | ||||
| Trade receivables, net of allowance for credit losses of $380 as of December 31, 2023 | ||||
| Restricted deposits | ||||
| Trade receivables, net of allowance for credit losses of $0 and $380 as of December 31, 2024 and 2023 | ||||
| Prepaid expenses and other receivables | ||||
| Inventory | ||||
| TOTAL CURRENT ASSETS | ||||
| Restricted deposits | ||||
| Operating lease right-of-use assets, net | ||||
| Property, plant and equipment, net | ||||
| Investment in joint venture | ||||
| Other asset | ||||
| TOTAL NON-CURRENT ASSETS | ||||
| TOTAL ASSETS | ||||
| CURRENT LIABILITIES: | ||||
| Trade payables | ||||
| Deferred revenue | ||||
| Other payables | ||||
| Current maturities of European Investment Bank (“EIB”) Loan | ||||
| Current maturities of operating lease liabilities | ||||
| TOTAL CURRENT LIABILITIES | ||||
| NON-CURRENT LIABILITIES: | ||||
| European Investment Bank (“EIB”) Loan | ||||
| Share based payment liability | ||||
| Warrants’ liability | ||||
| Operating lease liabilities | ||||
| TOTAL NON-CURRENT LIABILITIES | ||||
| TOTAL LIABILITIES | ||||
| SHAREHOLDERS’ EQUITY: | ||||
| Ordinary Shares, no par value - Authorized 150,000,000 and 15,000,000 as of December 31, 2025 and December 31, 2024, respectively ; Issued and outstanding 715,852 and 231,280 as of December 31, 2025 December 31, 2024, respectively | ||||
| Additional paid in capital | ||||
| Foreign currency cumulative translation reserve | ||||
| Accumulated deficit | ||||
| TOTAL SHAREHOLDERS’ EQUITY | ||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||
Loading...